ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
64 009,66
0,18%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ClearPoint Neuro Inc (CLPT)

  7. ClearPoint Neuro Inc (CLPT) Actualités

CLPT ClearPoint Neuro Inc

5,94
0,42 (7,61%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
ClearPoint Neuro Inc CLPT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,42 7,61% 5,94 23:11:01
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,59 5,59 5,88 5,87 5,52
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202422:05GLOBEClearPoint Neuro to Present Novel Research and Exhibit at..
29/4/202414:00GLOBEClearPoint Neuro Announces FDA Clearance of Prism Bone..
24/4/202422:05GLOBEClearPoint Neuro Announces Initiation of Limited Market..
23/4/202422:05GLOBEClearPoint Neuro to Announce First Quarter 2024 Results May..
16/4/202422:05GLOBEClearPoint Neuro Congratulates its Partner AviadoBio on..
19/3/202413:07GLOBEClearPoint Neuro Congratulates its Partner PTC Therapeutics..
12/3/202421:05GLOBEClearPoint Neuro Reports Fourth Quarter and Full-Year 2023..
11/3/202413:00GLOBEJournal of Neurosurgery Publication Demonstrates Distinct..
08/3/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:05GLOBEClearPoint Neuro to Announce Fourth Quarter and Full Year..
01/3/202414:00EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
29/2/202414:00GLOBEClearPoint Neuro Announces Pricing of Public Offering of..
28/2/202422:45GLOBEClearPoint Neuro Launches Proposed Public Offering of Common..
24/2/202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:05GLOBEClearPoint Neuro Announces FDA Clearance and First-in-Human..
06/2/202422:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202422:05GLOBEClearPoint Neuro Announces Installation and First Procedure..
22/1/202422:05GLOBEClearPoint Neuro Announces First EU MDR Certification..
16/1/202414:00GLOBEClearPoint Neuro Announces FDA Clearance for SmartFrame OR™..
08/1/202422:07EDGAR2Form 8-K - Current report
08/1/202422:05GLOBEClearPoint Neuro Reports Fourth Quarter and Full Year 2023..
04/1/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202417:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202417:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13/11/202315:22EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202323:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:05GLOBEClearPoint Neuro Reports Third Quarter 2023 Results
26/10/202322:05GLOBEClearPoint Neuro to Announce Third Quarter 2023 Results..
12/10/202320:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202318:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202318:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202323:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:06EDGAR2Form 8-K - Current report
08/8/202322:05GLOBEClearPoint Neuro Reports Second Quarter 2023 Results
01/8/202322:48EDGAR2Form 8-K - Current report
25/7/202322:05GLOBEClearPoint Neuro to Announce Second Quarter 2023 Results..
11/7/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202318:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
CLPT
ClearPoint Neuro
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés